Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2026-01-08
Summary
investigate the molecular differences between primitive lung cancer and the metastatic site.
Conditions
- NSCLC
- Lung Cancer (Diagnosis)
Sponsors & Collaborators
-
European Institute of Oncology
lead OTHER
Principal Investigators
-
Lorenzo Spaggiari · European Institute of Oncology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-18
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-31
Countries
- Italy
Study Locations
More Related Trials
-
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT02035683 ·Status: UNKNOWN ·Phase: NA
-
Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
NCT02785562 ·Status: COMPLETED ·Phase: NA
-
Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients
NCT05619562 ·Status: COMPLETED
-
Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma
NCT05072561 ·Status: UNKNOWN ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 ·Status: COMPLETED
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Evolution of Multiple Primary Lung Cancer (Evolution)
NCT04326751 ·Status: UNKNOWN
-
EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
NCT07096258 ·Status: RECRUITING
-
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
NCT06483919 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
NCT02758314 ·Status: UNKNOWN
-
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT07288632 ·Status: RECRUITING
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC
NCT06808113 ·Status: ACTIVE_NOT_RECRUITING
-
Cognitive Screening in Lung Cancer Patients
NCT06727370 ·Status: RECRUITING
-
Individualized Treatment of Patients With Advanced NSCLC: Potential Application for Circulating Tumor Cells (CTC) Molecular and Phenotypical Profiling
NCT02407327 ·Status: COMPLETED
-
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
NCT06800586 ·Status: RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma
NCT03156868 ·Status: COMPLETED
-
Ambispective Registry of Patients Affected by Lung Cancer
NCT07274163 ·Status: RECRUITING
-
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
NCT00003901 ·Status: COMPLETED ·Phase: PHASE3
-
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT06086574 ·Status: RECRUITING